Vasoactive Drugs in Intensive Care Unit
Vasoactive Drugs in Intensive Care Unit
Recruiting · NCT02118467 · Registry updated 2026-01-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vasoactive Drugs in Intensive Care Unit | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Tachycardia, Urogenital Diseases, atrial fibrillation, cardiovascular disorder, diabetes insipidus, endocrine system disorder, heart disorder, kidney disorder, pituitary gland disorder, urinary system disorder | Recruiting | Phase 4 | 2026-01-13 | NCT02118467 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Chicago | 326 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Chicago Medical Center | Chicago | United States | 152 |